Company research
HealthLynked Corp
CIK 1680139Updated Sep 25, 2026
SecurityHLYK · OTC · equity
HLYK price & chart
Loading TradingView…
OTC:HLYK on TradingView ↗About the company
HealthLynked Corp. (the “Company,” “we,” “our,”) is a healthcare technology company incorporated in the State of Nevada on August 6, 2014. We operate across three primary divisions – Digital Healthcare, Health Services, and Medical Distribution – each dedicated to leveraging innovative solutions that enhance patient care, reduce costs, and generate long-term value for stockholders.
In the news
HealthLynked Launches New Consumer Platform and Multi-Site Digital Ecosystem to Redefine the Front Door to Healthcare ↗
Recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 1,702,346Source | 2,222,989Source | 4,280,140Source | 4,580,716Source |
| Property, Plant and Equipment, NetUSD | 74,705Source | 176,576Source | 290,755Source | 413,123Source |
| GoodwillUSD | — | — | — | 319,958Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 37,136Source | 76,241Source | 247,222Source | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | — | 20,861Source | 72,284Source |
| Inventory, NetUSD | 17,962Source | 44,686Source | 133,222Source | 192,833Source |
| Assets, CurrentUSD | 1,551,551Source | 1,641,164Source | 656,160Source | 2,144,540Source |
| Prepaid Expense and Other Assets, CurrentUSD | 32,935Source | 56,719Source | 50,100Source | 92,940Source |
| Operating Lease, Right-of-Use AssetUSD | 76,090Source | 361,109Source | 935,812Source | 540,181Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 7,464,197Source | 5,352,198Source | 3,475,410Source | 4,266,266Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 2,750Source | 2,750Source | 2,750Source | 2,750Source |
| Common Stock, Value, IssuedUSD | 288Source | 28,195Source | 27,597Source | 25,594Source |
| Additional Paid in CapitalUSD | 44,712,980Source | 44,842,829Source | 42,525,837Source | 41,081,455Source |
| Retained Earnings (Accumulated Deficit)USD | -50,539,218Source | -48,164,615Source | -42,033,136Source | -41,020,933Source |
| Stockholders' Equity Attributable to ParentUSD | -5,761,851Source | -3,129,209Source | 804,730Source | 314,450Source |
| Liabilities and EquityUSD | 1,702,346Source | 2,222,989Source | 4,280,140Source | 4,580,716Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 7,013,275Source | 4,689,996Source | 2,412,024Source | 3,474,697Source |
| Operating Lease, Liability, CurrentUSD | 75,168Source | 208,549Source | 326,033Source | 344,464Source |
| Operating Lease, Liability, NoncurrentUSD | 922Source | 153,592Source | 613,386Source | 198,330Source |
| Additional Financial Items | ||||
| Accounts Receivable, after Allowance for Credit LossUSD | — | — | — | 98,180Source |
| Accrued Liabilities, CurrentUSD | 177,204Source | 90,462Source | 91,238Source | — |
| Deferred Compensation EquityUSD | — | 0Source | 64,647Source | — |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | — | 45,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 101,871Source | 282,950Source | 352,027Source | 829,481Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 158,625Source | 210,333Source | — | 100,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | — | -20,861Source | -28,916Source | -36,510Source |
| Increase (Decrease) in InventoriesUSD | -26,724Source | -88,536Source | -59,611Source | 44,631Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -1,713,810Source | -3,494,122Source | -4,144,868Source | -4,363,020Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | 313,802Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 125,000Source | 422,402Source | 3,506,112Source | -544,750Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | 2,598Source | 1,500Source | 23,564Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 1,549,705Source | 2,900,739Source | 824,087Source | 1,678,015Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | -3,229,755Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 37,136Source | 76,241Source | 247,222Source | 61,891Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 15,351Source | 26,316Source | 21,041Source | 5,923Source |
| Income Taxes Paid, NetUSD | 10,000,000Source | 10,000,000Source | 10,000,000Source | — |
| Additional Financial Items | ||||
| AmortizationUSD | — | — | 10,353Source | 46,771Source |
| Share-based Payment Arrangement, ExpenseUSD | 53,776Source | — | — | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | 828,006Source | 1,316,165Source | 427,808Source | 33,752Source |
| Amortization of Intangible AssetsUSD | 0Source | 167,848Source | 228,159Source | 715,800Source |
| AssetAcquisitionContingentConsiderationLiabilityUSD | — | — | 2,189Source | 198,307Source |
| DepreciationUSD | 101,871Source | 115,102Source | 123,868Source | 113,681Source |
| Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of TaxUSD | -2,113,254Source | — | — | -748,262Source |
| Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of TaxUSD | — | -474,200Source | -253,800Source | — |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | 86,298Source | 11,094Source | — |
| Financing Interest ExpenseUSD | — | — | — | 110,000Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | 0Source | — | — | — |
| Gain (Loss) on Disposition of AssetsUSD | 168,722Source | — | — | — |
| Gain (Loss) on Sale of InvestmentsUSD | — | — | — | 632,826Source |
| Gain (Loss) on Disposition of Other AssetsUSD | 168,722Source | — | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | 1,675Source | — | — |
| Gain (Loss) on Termination of LeaseUSD | 30,146Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | 317,982Source | -178,986Source | -145,212Source | — |
| GoodwillUSD | — | — | — | 319,958Source |
| Goodwill, Impairment LossUSD | — | 716,000Source | 319,958Source | 2,745,563Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | 0Source | — | 1,979,314Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -3,280,254Source | -6,131,479Source | -3,613,951Source | -8,067,482Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 2,601,748Source | -748,262Source |
| Income (Loss) from Equity Method InvestmentsUSD | -3,280,300Source | -6,131,500Source | -1,012,200Source | — |
| Insured Event, Gain (Loss)USD | — | — | — | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -3,280,254Source | -6,131,479Source | -1,012,203Source | -8,815,744Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -1,012,203Source | -9,169,315Source |
| Nonoperating Income (Expense)USD | -1,167,000Source | -1,453,831Source | 537,760Source | -22,825Source |
| Operating Costs and ExpensesUSD | 4,178,546Source | 7,686,009Source | 9,874,090Source | 1,088,127Source |
| Operating ExpensesUSD | 4,178,546Source | 7,686,009Source | — | 14,517,576Source |
| Operating Lease, ExpenseUSD | 241,504Source | 477,063Source | 468,901Source | — |
| Other Operating Income (Expense), NetUSD | — | — | — | 591,892Source |
| Proceeds from Issuance of Common StockUSD | 30,000Source | 405,000Source | 850,000Source | 956,787Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 2,065,292Source | — | — | 5,407,416Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | — | 3,008,361Source | 5,722,379Source | 5,858,202Source |
| Selling, General and Administrative ExpenseUSD | 2,035,516Source | 3,038,936Source | 3,623,402Source | 4,577,490Source |
| Operating Income (Loss)USD | -2,113,254Source | -4,677,648Source | -4,151,711Source | -8,659,374Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | -6,131,479Source | -3,613,951Source | -8,067,482Source |
| Net Income (Loss) Attributable to ParentUSD | -3,280,254Source | -6,131,479Source | -1,012,203Source | -8,815,744Source |
| Earnings Per Share, BasicUSD per share | -1.16Source | -0.02Source | 0Source | -0.04Source |
| Earnings Per Share, DilutedUSD per share | -1.16Source | -0.02Source | 0Source | -0.04Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 2,835,764Source | 281,544,002Source | 262,891,873Source | 243,419,736Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 2,835,764Source | 281,544,002Source | 262,891,873Source | 243,419,736Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 0Source | 167,848Source | 228,159Source | 715,800Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 101,871Source | 282,950Source | 352,027Source | 829,481Source |
| Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of TaxUSD | — | -474,200Source | -253,800Source | — |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | 86,298Source | 11,094Source | — |
| Financing Interest ExpenseUSD | — | — | — | 110,000Source |
| Goodwill, Impairment LossUSD | — | 716,000Source | 319,958Source | 2,745,563Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -3,280,254Source | -6,131,479Source | -3,613,951Source | -8,067,482Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -3,280,300Source | -6,131,500Source | -1,012,200Source | -8,815,700Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | -0.02Source | -0.01Source | -0.04Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | -0.02Source | -0.01Source | -0.04Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 2,601,748Source | -748,262Source |
| Income (Loss) from Equity Method InvestmentsUSD | -3,280,300Source | -6,131,500Source | -1,012,200Source | — |
| Interest ExpenseUSD | — | — | 21,331Source | — |
| Interest Income, OtherUSD | — | — | 21,530Source | 6,503Source |
| Labor and Related ExpenseUSD | 1,016,543Source | 1,995,127Source | 3,231,117Source | 3,335,695Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -1,012,203Source | -9,169,315Source |
| Nonoperating Income (Expense)USD | -1,167,000Source | -1,453,831Source | 537,760Source | -22,825Source |
| Operating Costs and ExpensesUSD | 4,178,546Source | 7,686,009Source | 9,874,090Source | 1,088,127Source |
| Operating ExpensesUSD | 4,178,546Source | 7,686,009Source | — | 14,517,576Source |
| Operating Lease, ExpenseUSD | 241,504Source | 477,063Source | 468,901Source | — |
| Other Cost and Expense, OperatingUSD | 973,048Source | 1,556,759Source | 2,205,085Source | 2,566,191Source |
| Other Cost of Operating RevenueUSD | — | — | — | 339,865Source |
| Other Operating Income (Expense), NetUSD | — | — | — | 591,892Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 2,065,292Source | — | — | 5,407,416Source |
Offerings
Registration 333-293324
Filing attachments
ea028603101ex4-10.htm · S-1/A · 2026-04-30
EX-4.10 3 ea028603101ex4-10.htm FORM OF COMMON SHARE PURCHASE WARRANT DATED JANUARY 22, 2026 Exhibit 4.10 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGI…
Read attachment ↗ea028603101ex4-9.htm · S-1/A · 2026-04-30
EX-4.9 2 ea028603101ex4-9.htm CONVERTIBLE PROMISSORY NOTE DATED JANUARY 22, 2026 Exhibit 4.9 THIS NOTE HAS BEEN ISSUED WITH “ORIGINAL ISSUE DISCOUNT” FOR U.S. FEDERAL INCOME TAX PURPOSES. THE ISSUER WILL MAKE AVAILABLE TO ANY HOLDER OF THIS NOTE: (1) THE ISSUE PRICE AND ISSUE DATE OF THE NOTE, (2) THE AMOUNT OF ORIGINAL ISSUE DISCOUNT ON THE NOTE, (3) THE YIELD TO MATURITY OF THE NOTE, AND (4) ANY OTHER INFORMATION REQUIRED TO BE MADE AVAILABLE BY U.S. TREASURY REGULATIONS UPON RECEIVING A …
Read attachment ↗ea027563901ex99-1_health.htm · S-1 · 2026-02-10
EX-99.1 16 ea027563901ex99-1_health.htm EXECUTIVE OFFICER COMPENSATION CLAWBACK POLICY Exhibit 99.1 HEALTHLYNKED CORP. NASDAQ RULE 5608 EXECUTIVE OFFICER COMPENSATION CLAWBACK Policy Effective FEBRUARY 8, 2026 1. Policy Purpose. The purpose of this HealthLynked Corp. Nasdaq Rule 5608 Executive Officer Compensation Clawback Policy (this “Policy”) is to enable HealthLynked Corp. and its subsidiaries and affiliates (the “Company”) to recover Erroneously Awarded Compensation in the event that…
Read attachment ↗ea026932601ex99-1_health.htm · 8-K · 2025-12-12
EX-99.1 2 ea026932601ex99-1_health.htm PRESS RELEASE DATED DECEMBER 2, 2025 Exhibit 99.1 HealthLynked Expands Board of Directors With Addition of Two Leading Insurance Executives: Chris G. Pulos of Marsh McLennan and Jason Bishara of NSI Insurance NAPLES, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) - via IBN - HealthLynked Corp. (OTCQB:HLYK), an AI-driven global healthcare network focused on improving care coordination and reducing healthcare costs, today announced the appointment of two nationa…
Read attachment ↗ea026932601ex99-2_health.htm · 8-K · 2025-12-12
EX-99.2 3 ea026932601ex99-2_health.htm PRESS RELEASE DATED DECEMBER 8, 2025 Exhibit 99.2 HealthLynked Appoints Duncan McGillivray as Chief Operating Officer to Accelerate National Expansion and Nasdaq Uplisting Strategy NAPLES, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) - via IBN - HealthLynked Corp. (OTCQB: HLYK), the nation’s leading patient-centric healthcare networking platform, today announced the appointment of Duncan McGillivray, MBA, as its new Chief Operating Officer (COO). McGillivray …
Read attachment ↗ea025610001ex99-1_health.htm · 8-K · 2025-09-05
EX-99.1 3 ea025610001ex99-1_health.htm PRESS RELEASE DATED SEPTEMBER 4, 2025 Exhibit 99.1 Reverse Stock Split Strengthens HealthLynked’s Market Position as Company Scales AI-Driven Healthcare Platform NAPLES, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK) -- Dear Shareholders, I’m writing to share an important update in the continued evolution of HealthLynked Corp. that reflects our commitment to long-term growth and enhanced shareholder value. We’ve…
Read attachment ↗